Wyndly Analysis: $2.0M Raised
What is Wyndly?
Wyndly offers sublingual immunotherapy to treat environmental allergies, providing personalized treatment plans delivered to patients' homes. The company focuses on retraining the immune system to reduce allergy symptoms and improve overall health.
HQ Country
New York City, United States
Employees
1-10
Founded
2021
Product Features & Capabilities
- Sublingual immunotherapy treatment plans
- At-home allergy testing
- Virtual consultations with board-certified doctors
- Allergy drops and tablets
- Monthly therapy plans starting at $99
How much Wyndly raised
1 - $2 million
January 15, 2025Lead Investor: Y Combinator, Goodwater Capital
